Live from the NIH registry
Studies recruiting near Reading right now
Top 25 of 266 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Lancaster General Hospital — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Lancaster General Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: NRG Oncology
A Study of MZE782 in Adults With PKU
Phenylketonuria (PKU)
Phase 2
Interventional 38 participants sought
Clinic for Special Children — Gordonville, Pennsylvania (24.7 mi)
· Sponsor: Maze Therapeutics
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
St Luke's University Health, Sacred Heart Campus — Allentown, Pennsylvania (29.5 mi)
· Sponsor: GT Medical Technologies, Inc.
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Geisinger Cancer Services-Pottsville — Pottsville, Pennsylvania (27.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Direct vs Indirect Methods for Cascade Screening
Long QT Syndrome, Familial Hypercholesterolemia
N/A
Interventional 200 participants sought
University of Maryland Amish Research Clinic — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: University of Maryland, Baltimore
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
Oligometastatic Breast Carcinoma, Breast Cancer
Phase 2
Interventional 46 participants sought
Lehigh Valley Health Network (Data Collection Only) — Allentown, Pennsylvania (29.5 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
Diabetes Mellitus, Type 2, Diabetes Education
N/A
Interventional 65 participants sought
Reading Hospital, an affiliate of Tower Health — West Reading, Pennsylvania (1.2 mi)
· Sponsor: The Reading Hospital and Medical Center
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — Allentown, Pennsylvania (29.5 mi)
· Sponsor: Seaport Therapeutics
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Ability x Ottobock.care — Wyomissing, Pennsylvania (2.2 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi)
· Sponsor: NRG Oncology
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Phase 3
Interventional 1,800 participants sought
Lehigh Center for Clinical Research — Allentown, Pennsylvania (29.5 mi)
· Sponsor: TriGemX Bio, Inc.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Penn State Health Saint Joseph Medical Center — Reading, Pennsylvania (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Amblyopia
Phase 3
Interventional 252 participants sought
Conestoga Eye — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: Jaeb Center for Health Research
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Keystone Urology Specialists — Lancaster, Pennsylvania (28.9 mi)
· Sponsor: Ferring Pharmaceuticals
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Geisinger Cancer Services-Pottsville — Pottsville, Pennsylvania (27.7 mi)
· Sponsor: Eastern Cooperative Oncology Group
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi)
· Sponsor: SWOG Cancer Research Network
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial Cancer, Endometrioid Adenocarcinoma
N/A
Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (29.5 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Reading Hospital and Medical Center — West Reading, Pennsylvania (1.2 mi)
· Sponsor: Gilead Sciences
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (17.3 mi)
· Sponsor: NRG Oncology
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
PA Regional Center for Arthritis and Osteoporosis Research — Wyomissing, Pennsylvania (2.2 mi)
· Sponsor: Takeda
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (29.5 mi)
· Sponsor: Inhibrx Biosciences, Inc
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (29.5 mi)
· Sponsor: National Cancer Institute (NCI)